The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 5

More JCP Articles

JCP
What Clinicians Should Know About the Pragmatic Use of Xanomeline-Trospium Combination
ASCP Corner

June 9, 2025

This article will help familiarize clinicians with practical issues in the use of xanomeline-trospium and its entry into the pharmacopoeia for schizophrenia.
,
JCP
Administering Semaglutide With Long-Term Olanzapine Use
Case Report

June 9, 2025

This report describes use of the GLP-1R agonist semaglutide in a patient with schizophrenia and severe, olanzapine-induced weight gain that was resistant to alternative treatments.
, , , et al
JCP
The Dopamine-3 Receptor in the Treatment of Schizophrenia: Part 1
Insights

June 6, 2025

In Part I of his video, Dr. Ragy Girgis highlights the D3 receptor as a promising target in schizophrenia, with potential to address negative and cognitive symptoms unmet by…
JCP
The Dopamine-3 Receptor in the Treatment of Schizophrenia: Part 2
Insights

June 6, 2025

In Part II of his video, Dr. Ragy Girgis examines D3 receptor binding by antipsychotics and its potential to improve negative symptoms in schizophrenia.
JCP
Cognitive Behavioral Therapy for Insomnia with Prolonged Exposure Compared to Sleep Hygiene and Prolonged Exposure
Original Research

June 4, 2025

On average, participants had reductions in PTSD symptoms, with no differences between the treatment groups. CBT for insomnia with prolonged exposure produced greater reductions in insomnia symptoms and increases…
, , , et al
JCP
What Is Meant by the Term “Deprescribing,” and Does It Belong in Our Lexicon?
ASCP Corner

June 2, 2025

The authors encourage the field to destigmatize the term “deprescribing” from its misappropriated usage, explicate its accurate definition, and reclaim its purposeful meaning.
, , , et al
JCP
Risk of Alzheimer’s Disease and Vascular Dementia in Patients With Peripheral Vestibular Disorders
Original Research

June 2, 2025

The authors found that peripheral vestibular disorders are a risk factor for dementia, regardless of psychiatric comorbidities.
, , , et al
JCP
Idiopathic Hypersomnia: Recognition and Management in Psychiatric Practice
Narrative Review

June 2, 2025

Idiopathic hypersomnia, characterized by excessive daytime sleepiness (EDS), has an estimated population prevalence up to 1.5%. Psychiatric medications may exacerbate EDS and, conversely, idiopathic hypersomnia treatments may exacerbate psychiatric…
, , , et al
JCP
Detecting Tardive Dyskinesia Using Video-based AI
Original Research

May 28, 2025

The algorithm reliably detected suspected tardive dyskinesia, reaching higher sensitivity and specificity than trained raters using the standard assessment.
, , , et al
JCP
Outpatient Ketamine Prescribing Practices in Psychiatry in the US: A Nationwide Survey Study
Original Research

May 26, 2025

There is significant variability in ketamine treatment in the community including indications, treatment duration, formulation, and setting of use. Increased oversight and specific practice guidelines are needed to ensure…
, ,
JCP
Prediction Of Adolescent Suicidal Events By Residual Depressive Symptoms
Original Research

May 21, 2025

Sleep disturbance and suicidal ideation were the strongest predictors of hospitalization, and, together with anhedonia, they consistently predicted suicidal events during follow-up.
, , , et al
JCP
Postpartum Distress in Women With and Without ADHD
Original Research

May 19, 2025

Women with ADHD were 1.14 times more likely to be diagnosed with mood disorder at 6 weeks postpartum and 1.21-1.24 times more likely to be diagnosed with a mood,…
, ,

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe